FERRARO, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.316
EU - Europa 3.075
AS - Asia 1.120
OC - Oceania 28
SA - Sud America 18
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.272
GB - Regno Unito 1.395
IT - Italia 431
SE - Svezia 360
HK - Hong Kong 318
CN - Cina 307
DE - Germania 236
SG - Singapore 222
UA - Ucraina 166
FI - Finlandia 124
BG - Bulgaria 116
TR - Turchia 108
FR - Francia 94
KR - Corea 34
CA - Canada 33
ID - Indonesia 28
AU - Australia 27
IR - Iran 24
IN - India 21
CZ - Repubblica Ceca 20
IE - Irlanda 20
BE - Belgio 19
RU - Federazione Russa 17
JP - Giappone 14
CH - Svizzera 12
PL - Polonia 12
MY - Malesia 11
NL - Olanda 11
BZ - Belize 10
CL - Cile 8
AT - Austria 7
ES - Italia 6
LT - Lituania 5
BD - Bangladesh 4
DK - Danimarca 4
GR - Grecia 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BR - Brasile 3
IL - Israele 3
NO - Norvegia 3
PH - Filippine 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
LU - Lussemburgo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
VN - Vietnam 2
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
UY - Uruguay 1
Totale 13.562
Salva come PNG Salva come JPEG
Città #
Fairfield 1.818
Southend 1.203
Woodbridge 872
Ashburn 819
Seattle 705
Houston 690
Chandler 619
Cambridge 604
Wilmington 532
Ann Arbor 353
Dearborn 317
Hong Kong 316
Jacksonville 285
Nyköping 280
Modena 150
Singapore 146
San Diego 138
Princeton 118
Sofia 116
New York 107
Helsinki 100
Eugene 73
Beijing 72
London 54
Bremen 46
Izmir 44
Redwood City 42
Norwalk 39
Boardman 30
Shanghai 29
Jakarta 28
Fremont 25
Seongnam 23
Dublin 20
Falls Church 18
Milan 18
Brussels 17
Hefei 17
Kunming 17
Guangzhou 16
Piacenza 16
Kilburn 15
Phoenix 14
Prescot 14
Edinburgh 13
Olomouc 12
Toronto 12
Chiswick 11
Nanjing 11
Belize City 10
Andover 9
Chicago 9
Washington 9
Des Moines 8
Frankfurt am Main 8
Ottawa 8
Rome 8
Serramazzoni 8
Zanjan 8
Acton 7
Bologna 7
Hounslow 7
Las Vegas 7
Paris 7
Rimini 7
San Francisco 7
San Jose 7
Leawood 6
Los Angeles 6
Nanchang 6
Parma 6
Vienna 6
Amsterdam 5
Brno 5
Hebei 5
Melbourne 5
Polska 5
Seoul 5
Berlin 4
Buffalo 4
Dallas 4
Dongguan 4
Islington 4
Istanbul 4
Jinan 4
Sacramento 4
Senigallia 4
Aberdeen 3
Athens 3
Atlanta 3
Bangalore 3
Benevento 3
Brescia 3
Buenos Aires 3
Columbus 3
Dhaka 3
Fidenza 3
Florence 3
Grafing 3
Indiana 3
Totale 11.310
Salva come PNG Salva come JPEG
Nome #
Definitive childlessness in women with multiple sclerosis: a multicenter study 552
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis 271
iNKT cells in secondary progressive multiple sclerosis patients display pro-inflammatory profiles 246
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 242
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 215
A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord 213
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: Results from an observational study 212
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome 209
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 200
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 199
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study 192
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 190
Acute hemichorea as unusual first multiple sclerosis presentation 188
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 186
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis 184
Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis 184
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 183
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis 181
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 179
Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient 176
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS 175
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect? 168
False positive absent somatosensory evoked potentials in cardiac arrest with therapeutic hypothermia. 167
Semiautomated segmentation of the human spine based on echoplanar images 166
Antiepileptic drugs in the treatment of headache: Neuroprotective effect or something else? 165
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 165
Severe anemia in a patient with multiple sclerosis treated with natalizumab 164
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 163
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 163
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients 161
Charcot-Marie-Tooth and pain: Correlations with neurophysiological, clinical, and disability findings 158
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study 158
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 157
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis 156
Acute necrotizing encephalopathy: A relapsing case in a European adult [4] 155
Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome 155
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia 155
Topiramate in the prevention of pediatric migraine: Literature review 154
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients 154
The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate 152
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 151
Antiepileptic drugs in the preventive treatment of migraine in children and adolescents 151
Diagnostics of dysimmune peripheral neuropathies 150
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 149
Diagnostics of anti-MAG antibody polyneuropathy 149
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis 149
Paroxysmal ventricular tachicardia and pure right insular stroke 147
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 145
Letter to Editor: Carpal tunnel syndrome due to an atypical deep soft tissue leiomyoma: The risk of misdiagnosis and mismanagement 143
Left thalamomegaly in a patient with partial epilepsy 143
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study 142
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study 141
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine 140
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosis 140
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis 137
Multiple attack study on the available triptans in Italy versus placebo 136
Evidence of different spinal pathways for the warmth evoked potentials 132
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: Acetylcholinesterase activity cannot be considered a useful biomarker 132
Topiramate in migraine prophylaxis: A randomised double-blind versus placebo study 131
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis 129
Habituation to Pain in "Medication Overuse Headache": A CO2 Laser-Evoked Potential Study 128
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 128
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 125
Occupational head injury and subsequent glioma 119
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study 117
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy 111
Risk of secondary progressive multiple sclerosis: A longitudinal study 109
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis 108
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 108
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study) 106
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 97
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders 96
Treatment response score to glatiramer acetate or interferon beta-1a 94
Antiepileptic drugs in migraine prophylaxis: state of the art 93
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients 92
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder 81
Informing MS patients on treatment options: a consensus on the process of consent taking 79
Association of Sustained Immunotherapy with Disability Outcomes in Patients with Active Secondary Progressive Multiple Sclerosis 78
Inter-center agreement in the interpretation of oligoclonal bands 75
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 70
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 62
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis 62
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 61
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 61
Microglia activation: A role for mitochondrial DNA? 61
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 57
Modulation of tregs and inkt by fingolimod in multiple sclerosis patients 53
A novel SOD1 mutation in a young ALS patient associated with slowly progressive clinical course 52
Cell-based assays for the detection of MOG antibodies: a comparative study 51
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 50
Efficacy of mechanical thrombectomy in patients with ischemic stroke and cancer 49
Early clinical markers of aggressive multiple sclerosis 47
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score 47
A study of the CD45 exon 4 C77G polymorphism in a patient affected both by multiple sclerosis and pulmonary Langerhans' cell histiocytosis 46
Delay from treatment start to full effect of immunotherapies for multiple sclerosis 44
Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus 43
Slowly progressive ALS associated with a novel SOD1 D11Y mutation 37
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS 36
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies 32
Prognosis of primary progressive multiple sclerosis: do cerebrospinal fluid oligoclonal IgM bands play a role? 31
Totale 13.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.155 0 165 139 227 316 504 592 386 387 160 172 107
2020/20213.223 230 200 294 312 481 193 186 371 164 428 224 140
2021/20222.344 216 274 249 93 40 134 107 140 246 222 393 230
2022/20231.721 195 202 145 179 197 246 21 185 187 12 102 50
2023/20241.218 33 70 60 157 223 106 145 154 28 14 60 168
2024/2025174 149 25 0 0 0 0 0 0 0 0 0 0
Totale 13.761